Mycoplasma pneumonia

Background:

——————————————————————————
Atypical Organisms
——————————————————————————
>Chlamydophila pneumoniae
>Chlamydophila psittaci
>Coxiella burnetii
>Legionella species ( L. pneumophila)
>Mycoplasma pneumonia led

Mycoplasma pneumonia

  • Causes “walking pneumonia”  (relatively slow progression of symptoms). 
  • Spread through respiratory droplet transmission (attachment sites include: upper and lower respiratory tract, causing pharyngitis, bronchitis, and pneumonia).
  • The infection is called atypical pneumonia because of its protracted course and lack of sputum production and wealth of extra-pulmonary symptoms.
  • Chronic mycoplasma infections have been implicated in the pathogenesis of rheumatoid arthritis and other rheumatological diseases.

 

top of page

Therapy:

Important considerations:  The choice of an agent should be based on local antimicrobial sensitivities, site of infection, cost, and comorbid conditions.   Generally, the most common agents/regimens are listed first.  Adjust length of therapy based on clinical course.

  1. Doxycycline 100mg orally or IV twice daily x 7-10 days
  2. Azithromycin  500mg orally x 1 then 250mg  once daily for 4 days
  3. Clarithromycin 500mg orally twice daily x 7 days
  4. Levofloxacin 750 mg IV/PO once daily  x 5-7 days

Disclaimer

The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user’s use of or reliance upon this material.PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read the disclaimer